Evidence map›Paper›PMID 36060915›Full record

ArticleIranian journal of pharmaceutical research : IJPR2022

New Cytotoxic Premyrsinane-Type Diterpenes from

Behzad Zolfaghari, Ali Farahani, Amin Jannesari, Mahmoud Aghaei, Mustafa Ghanadian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Diterpenoids fromMetabolites · 2023
    Article
  4. Bioassay-guided isolation inResearch in pharmaceutical sciences
    Article
  5. Malleatin A and B: New Premyrsine-Type Diterpenes fromIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Behzad ZolfaghariDepartment of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Science, Isfahan, Iran.
Ali FarahaniDepartment of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Science, Isfahan, Iran.
Amin JannesariDepartment of Pharmacognosy, School of Pharmacy, Isfahan University of Medical Science, Isfahan, Iran.
Mahmoud AghaeiDepartment of clinical Biochemistry, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-1775-8761
Mustafa GhanadianPhytochemistry Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.ORCID https://orcid.org/0000-0001-6446-4734

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast CancerDiterpeneEuphorbia aleppicaMCF-7MDA-MB 231Premyrsinane

Identifiers

PMID36060915
PMCPMC9420223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.